Environmentally responsive ophthalmic gel formulation of carteolol hydrochloride

Drug Delivery: Journal of Delivery and Targeting of Therapeutic Agents

Volumn 13, Issue 1, 2006, Pages 55-59

  El Kamel, Amal ^a,b   Al Dosari, Heba ^a   Al Jenoobi, Fahad ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Carteolol HCl; Gelrite; In Vitro; In Vivo; Ocular Bioavailability

Indexed keywords

CARTEOLOL; GELLAN; GELRITE; KELCOGEL; POLYMER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG FORMULATION; DRUG MONITORING; DRUG RELEASE; ENVIRONMENTAL FACTOR; GEL; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; VISCOSITY;

ABSORPTION; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CARTEOLOL; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIFFUSION; GELS; IRRITANTS; OPHTHALMIC SOLUTIONS; RABBITS; RHEOLOGY;

EID: 30644466466     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.1080/10717540500309073     Document Type: Article

References (17)

1. Bottari, F., Carelli, V., DiColo, G., Saettone, M. F., and Serafini, M. F. 1979. A new method for determining the diffusional coefficient of drugs in semi-solid vehicles from release data. Int. J. Pharm. 2:63-79.
2. Carlfors, J., Edsman, K., Petersson, R., and Jornuing, K. 1998. Rheological evaluation of Gelrite® in situ gels for ophthalmic use. Eur. J. Pharm. Sci. 6:113-119.
3. Chen-Chow, P. C., and Frank, S. 1981. In vitro release of lidocaine from pluronic F-127 gels. Int. J. Pharm. 8:89-99.
4. Chrisp, P., and Sokin, E. M. 1992. Ocular carteolol. A review of its pharmacological properties, and therapeutic use in glaucoma and ocular hypertension. Drug Aging 2:58-77.
5. Griffith, J. F., Nixon, G. A., Bruce, R. D., Reer, P. J., and Bannan, E. A. 1980. Dose-response studies with chemical irritants in the albino rabbit eye as a basis for selecting optimum testing conditions for predicting hazard to the human eye. Toxicol. Appl. Pharmacol. 55:501-513.
6. Gurtler, F., and Gurny, R. 1995. Patent literature review of ophthalmic inserts. Drug Develop. Ind. Pharm. 21:1-18.
7. Hernandez, A. I., Durand, S., Garnier, C., Tecante, A., and Doublier, J. L. 2003. Rheology-structure properties of gellan systems: evidence of network formation at low gellan concentrations. Food Hydrochlolloids 17:621-628.
8. Higuchi, W. I. 1962. Analysis of data on the medicament release from ointments. J. Pharm. Sci. 51:802-804.
9. Järvinen, T., Pate, D. W., and Lain, K. 2000. Cannabinoids in the treatment of glaucoma. Pharmacol. Ther. 295:203-220.
10. Lauffer, M. A. 1961. Theory of diffusion in gels. Biophys. J.1:205-213.
11. Lee, V. H. L., and Robinson, J. R. 1986. Review: topical ocular drug delivery: recent developments and future challenges. J. Ocul. Pharmacol. 2:67-108.
12. Lodge, A. S. 1956. A network theory of flow birefringence and stress in concentrated polymer solutions. Trans. Faraday Soc. 52:120-130.
13. Rozier, A., Mazuel, C., Grove, J., and Plazonnet, B. 1989. Gelrite - a novel, ion-activated, in situ gelling polymer for ophthalmic vehicles - effect on bioavailability of timolol. Int. J. Pharm. 57:163-168.
14. Sanzgiri, Y. D., Maschi, S., Crescenzi, V., Callegaro, L., Topp, E. M., and Stella, V. J. 1993. Gellan-based systems for ophthalmic sustained delivery of methyl-prednisolone. J. Control. Rel. 26:195-201.
15. Sasaki, H., Ichikawa, M., Kawakami, S., Yamamura, K., Mukai, T., Nishida, K., and Nakamura, J. 1997. In situ ocular absorption of ophthalmic beta-blockers through ocular membranes in albino rabbits. J. Pharm. Pharmacol. 49:140-144.
16. Sasaki, H., Igarachi, Y., Nagano, T., Nishida, K., and Nkamura, J. 1995. Different effects of absorption promoter on corneal and conjunctival penetration of ophthalmic beta blockers. Pharm. Res. 12:1146-1150.
17. Veyries, M. L., Couarraze, G., Geiger, S., Agnely, F., Massias, L., Kunzli, B., Faurisson, F., and Rouveix, B. 1999. Controlled release of vancomycin from poloxamer 407 gels. Int. J. Pharm. 192:183-193.